Track Categories

The track category is the heading under which your abstract will be reviewed and later published in the conference printed matters if accepted. During the submission process, you will be asked to select one track category for your abstract.

  • Track 1-1Pancreas Histology
  • Track 1-2Growth Hormone
  • Track 1-3Pancreas Atrophy
  • Track 1-4Adenocarcinoma of Pancreas
  • Track 1-5 Endocrine Pancreas
  • Track 1-6Ectopic Pancreas
  • Track 1-7Retroperitonial Pancreas
  • Track 1-8Overactive Pancreas
  • Track 1-9Enlarged Pancreas
  • Track 1-10 Exocrine Pancreas
  • Track 1-11Pancreas Function
  • Track 1-12Pancreatic and Periampullary Carcinoma
  • Track 2-1Pancreatic Cysts
  • Track 2-2Immunofluorescence and Immunohistochemistry
  • Track 2-3Biomarkers in Pancreatic Cancer
  • Track 2-4Biomarkers in Pancreatic Cancer
  • Track 2-5Molecular Diagnostics to Pancreatic Cancer
  • Track 2-6Western Blot Analysis and Albumin ELISA
  • Track 2-7RTPCR
  • Track 3-1Pancreatic Cancer
  • Track 3-2Diabetes Mellitus
  • Track 3-3Diabetes Mellitus
  • Track 3-4Hyperglycemia
  • Track 3-5Hyperglycemia
  • Track 3-6Cystic fibrosis
  • Track 4-1Pancreatic Tumors
  • Track 4-2Pancreatic Neuroendocrine Tumors
  • Track 4-3Benign Pancreatic Tumors
  • Track 4-4Advaces in Pancreatic Cyst Surgery
  • Track 4-5Pancreatic Oncology
  • Track 4-6Innovation in Pancreatic Cancer Treatment
  • Track 4-7Immunotherapeutic Approaches in Pancreatic Cancer
  • Track 4-8Vaccine in Pancreatic Cancer
  • Track 4-9Pancreatic Ductal Adenocarcinoma (PDAC)
  • Track 5-1Advanced diagnosis for IPMN pancreas
  • Track 5-2Advanced treatment for IPMN pancreas
  • Track 5-3Pseudocyst of Pancreas
  • Track 6-1Elevated Pancreatic Enzymes
  • Track 6-2Pancreatic Enzymes Supplements
  • Track 6-3Pancreatic Enzymes Replacements
  • Track 6-4Pancreatic Pseudocyst
  • Track 10-1Advanced Pancreatitis Diagnosis
  • Track 10-2Chronic Pancreatitis Treatment
  • Track 10-3Natural Treatment for Pancreatitis
  • Track 10-4Pancreaticobiliary Endoscopy
  • Track 10-5Early Detection of Sporadic Pancreatic Cancer
  • Track 10-6Clinical Controversy
  • Track 10-7Medical Breakthroughs in Prevention, Diagnosis and Treatment
  • Track 10-8 Pancreatic Pseudocyst Treatment
  • Track 10-9Feline Pancreatitis Treatment
  • Track 10-10Acute Pancreatitis Treatment
  • Track 11-1Alcoholic and Non-Alcoholic Liver diseases
  • Track 11-2Hepatic Encephalopathy
  • Track 11-3Fatty Liver Disease
  • Track 11-4Primary Biliary Cirrhosis
  • Track 11-5Nonalcoholic Steatohepatitis
  • Track 11-6Acute and Chronic Liver Disease
  • Track 11-7Fulminant Liver failure
  • Track 11-8Liver Cirrhosis
  • Track 11-9Hepatotoxicity
  • Track 12-1Liver Tests
  • Track 12-2Transient Elastography
  • Track 12-3Shear Wave Elastography
  • Track 12-4Fibroscan
  • Track 12-5 Liver imaging
  • Track 13-1 Hepatitis B: Management strategies
  • Track 13-2Novel Therapies for HBV
  • Track 13-3Novel Therapies for HBV
  • Track 13-4Prevention, Care and for Hepatitis B Infection
  • Track 13-5Recent Advances in Hepatitis C therapy
  • Track 13-6Prevention of HCV reinfection
  • Track 13-7HCV: Direct Acting Antiviral Era
  • Track 13-8Hepatitis C: Epidemiology
  • Track 13-9 HCV Kinetic Models and Implications in Drug Development
  • Track 13-10Treatment options in patients who failed DAA regimens
  • Track 13-11Hepatitis B Immunization in Infants
  • Track 13-12Hepatitis B Vaccine Clinical Research Trials
  • Track 14-1 Hepatitis Infection after Liver Transplantation
  • Track 14-2Complications of Liver Transplantation
  • Track 14-3 Long Term Complications following Liver Transplant
  • Track 14-4Living-donor Liver Transplant
  • Track 14-5Post-transplantation Care